Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 1/2 2Phase 4 1Phase 3 1

Status

Completed 70Terminated 22Active not recruiting 19Withdrawn 10Recruiting 6Unknown 5Not yet recruiting 1

Sponsor Class

OTHER 4NETWORK 1INDUSTRY 1

Study Type

Interventional 6

Sponsor

Cancer Type

Plasma cell 4Lymphoid 2Sarcoma 1Other hematologic neoplasm 1

Conditions

Multiple Myeloma 3Sarcoma, Kaposi 1Proteostasis Deficiencies 1Lymphoma, T-Cell, Peripheral 1Lymphoma, Non-Hodgkin 1Lymphoma, Mantle-Cell 1Leukemia, Myeloid, Acute 1Immunoglobulin Light-chain Amyloidosis 1Hematologic Neoplasms 1

Interventions

pembrolizumab 555Specimen Handling 459Carboplatin 446Magnetic Resonance Spectroscopy 427Cyclophosphamide 412Cisplatin 404Gemcitabine 314Radiotherapy 313Bevacizumab 310Paclitaxel 300Biopsy 260Drug Therapy 252Capecitabine 241Oxaliplatin 240fludarabine 236Nivolumab 226venetoclax 225Injections 214Docetaxel 203Fluorouracil 201Dexamethasone 186Radiosurgery 172Rituximab 161Pemetrexed 157durvalumab 144Standard of Care 143atezolizumab 139toripalimab 137tislelizumab 137Leucovorin 137

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Recruiting × Interventional × ixazomib × Clear all
NCT04305691 2026-02-27

Trial of Ixazomib for Kaposi Sarcoma

AIDS Malignancy Consortium

Phase 2 Recruiting
41 enrolled
Sarcoma

Sarcoma, Kaposi

NCT05722405 2026-01-05

Ixazomib Plus Low-dose Lenalidomide Versus Ixazomib Alone for Maintenance Treatment of High Risk Multiple Myeloma

Second Affiliated Hospital, School of Medicine, Zhejiang University

Phase 4 Recruiting
100 enrolled
Plasma cell

Multiple Myeloma

NCT04068597 2025-12-18

Study to Evaluate CCS1477 (Inobrodib) in Haematological Malignancies

CellCentric Ltd.

Phase 1/2 Recruiting
250 enrolled
LymphoidOther hematologic neoplasmPlasma cell

Lymphoma, Non-Hodgkin, Multiple Myeloma, Leukemia, Myeloid, Acute, Lymphoma, T-Cell, Peripheral, Hematologic Neoplasms

NCT05451771 2025-07-08

Venetoclax-Dexamethasone in Relapsed and/or Refractory t(11;14) Amyloidosis

Columbia University

Phase 1/2 Recruiting
53 enrolled
Plasma cell

Immunoglobulin Light-chain Amyloidosis, Proteostasis Deficiencies

NCT03616782 2023-10-06

Ixazomib Maintenance in Patients With Newly Diagnosed Mantle Cell Lymphoma(MCL)

Kosin University Gospel Hospital

Phase 2 Recruiting
98 enrolled
Lymphoid

Lymphoma, Mantle-Cell

NCT03562169 2018-06-19

The Role of Ixazomib in Autologous Stem Cell Transplant in Relapsed Myeloma - Myeloma XII (ACCoRd)

University of Leeds

Phase 3 Recruiting
406 enrolled
Plasma cell

Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡